Implication of human endogenous retroviruses in the development of autoimmune diseases

International Reviews of Immunology

Volumn 29, Issue 4, 2010, Pages 351-370

  Balada, Eva ^a   Vilardell Tarrés, Miquel ^a   Ordi Ros, Josep ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Autoimmunity; Human endogenous retroviruses; Insulin dependent diabetes mellitus; Lupus; Multiple sclerosis; Rheumatoid arthritis; Sjgren's syndrome

Indexed keywords

AUTOIMMUNE DISEASE; AVIAN LEUKOSIS ONCOVIRUS; ENDOGENOUS RETROVIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR MECHANICS; MOUSE MAMMARY TUMOR ONCOVIRUS; MULTIPLE SCLEROSIS; MURINE LEUKEMIA VIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIMIAN FOAMY VIRUS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; WALLEYE DERMAL SARCOMA VIRUS; BLOOD; CLASSIFICATION; CROSS REACTION; GENETICS; IMMUNOLOGY; METABOLISM; VIROLOGY;

ANTIBODIES, VIRAL; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CROSS REACTIONS; DIABETES MELLITUS, TYPE 1; ENDOGENOUS RETROVIRUSES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; SJOGREN'S SYNDROME; SUPERANTIGENS; VIRAL PROTEINS;

SUPERANTIGEN; VIRUS ANTIBODY; VIRUS PROTEIN;

EID: 77954791775     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2010.485333     Document Type: Review

References (119)

1. Rous P. A transmissible avian neoplasm (sarcome of the common fowl). J Exp Med 1910;12:696-705.
2. Rous P. A transmissible avian neoplasm (sarcome of the common fowl). J Exp Med 1911;13:397-411.
3. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A 1981;78:6476-6480.
4. Gallo RC, Montagnier L. The chronology of AIDS research. Nature 1987;326: 435-436.
5. Mahieux R, Gessain A. [New human retroviruses: HTLV-3 and HTLV-4.] Med Trop (Mars) 2005;65:525-528.
6. Temin HM. Separation of morphological conversion and virus production in Rous sarcoma virus infection. Cold Spring Harb Symp Quant Biol 1962;27: 407-414.
7. Leblanc P, Desset S, Giorgi F, et al. Life cycle of an endogenous retrovirus, ZAM, in Drosophila melanogaster. J Virol 2000;74:10658-10669.
8. Bowen NJ, McDonald JF. Genomic analysis of Caenorhabditis elegans reveals ancient families of retroviral-like elements. Genome Res 1999;9:924-935.
9. Laten HM, Majumdar A, and Gaucher EA. SIRE-1, a copia/Ty1-like retroelement from soybean, encodes a retroviral envelope-like protein. Proc Natl Acad Sci U S A 1998;95:6897-6902.
10. Boeke M, Stoye JP. In: Coffin JM, Hughes SH, and Varmus HE (Eds.). Retro- viruses. Plainview, NY: Cold Spring Harbor Lab. Press, 1997.
11. Levy JA. Xenotropic viruses: Murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains. Science 1973;182:1151-1153.
12. Turner G, Barbulescu M, Su M, et al. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol 2001;11:1531-1535.
13. Boller K, Schonfeld K, Lischer S, et al. Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J Gen Virol 2008;89:567-572.
14. Lower R, Lower J, and Kurth R. The viruses in all of us: Characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad SciU S A 1996;93:5177-5184.
15. Martin MA, Bryan T, Rasheed S, and Khan AS. Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci U S A 1981;78:4892-4896.
16. Repaske R, O'Neill RR, Steele PE, and Martin MA. Characterization and partial nucleotide sequence of endogenous type C retrovirus segments in human chromosomal DNA. Proc Natl Acad Sci U S A 1983;80:678-682.
17. Ono M, Kawakami M, and Ushikubo H. Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J Virol 1987;61:2059-2062.
18. Medstrand P, Blomberg J. Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: Differential transcription in normal human tissues. J Virol 1993;67: 6778-6787.
19. Tristem M. Identification and characterization of novel human endogenous retro- virus families by phylogenetic screening of the human genome mapping project database. J Virol 2000;74:3715-3730.
20. Mager DL, Henthorn PS. Identification of a retrovirus-like repetitive element in human DNA. Proc Natl Acad Sci U S A 1984;81:7510-7514.
21. Wilkinson DA, Mager DL, and Leong JAC. In: Levy JAP (Ed.): The Retroviridae. New York, pp. 465-535, 1994.
22. Coffin JM. Genetic diversity and evolution of retroviruses. Curr Top Microbiol Immunol 1992;176:143-164.
23. Perl A, Rosenblatt JD, Chen IS, et al. Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res 1989;17:6841-6854.
24. Nelson PN, Lever AM, Bruckner FE, et al. Polymerase chain reaction fails to incriminate exogenous retroviruses HTLV-I and HIV-1 in rheumatological diseases although a minority of sera cross react with retroviral antigens. Ann Rheum Dis 1994;53:749-754.
25. Nelson PN, Lever AM, Smith S, et al. Molecular investigations implicate human endogenous retroviruses as mediators of anti-retroviral antibodies in autoimmune rheumatic disease. Immunol Invest 1999;28:277-289.
26. di Giovine FS, Bailly S, Bootman J, et al. Absence of lentiviral and human T cell leukemia viral sequences in patients with rheumatoid arthritis. Arthritis Rheum 1994;37:349-358.
27. Herrmann M, Neidhart M, Gay S, et al. Retrovirus-associated rheumatic syndromes. Curr Opin Rheumatol 1998;10:347-354.
28. Rolland A, Jouvin-Marche E, Viret C, et al. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J Immunol 2006;176:7636-7644.
29. Balada E, Ordi-Ros J, and Vilardell-Tarres M. Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunity. Rev Med Virol 2009;19:273-286.
30. Andrews BS, Eisenberg RA, Theofilopoulos AN, et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978;148:1198-1215.
31. Izui S, McConahey PJ, Clark JP, et al. Retroviral gp70 immune complexes in NZB x NZW F2 mice with murine lupus nephritis. J Exp Med 1981;154: 517-528.
32. Vyse TJ, Drake CG, Rozzo SJ, et al. Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice. J Clin Invest 1996;98:1762-1772.
33. Tucker RM, Vyse TJ, Rozzo S, et al. Genetic control of glycoprotein 70 autoantigen production and its influence on immune complex levels and nephritis in murine lupus. J Immunol 2000;165:1665-1672.
34. Izui S, McConahey PJ, Theofilopoulos AN, and Dixon FJ. Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J Exp Med 1979;149:1099-1116.
35. Panem S, Ordonez NG, Kirstein WH, et al. C-type virus expression in systemic lupus erythematosus. N Engl J Med 1976;295:470-475.
36. Wu J, Zhou T, He J, and Mountz JD. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 1993;178: 461-468.
37. Tsao BP, Cantor RM, Kalunian KC, et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997;99:725-731.
38. Kotzin BL. Susceptibility loci for lupus: A guiding light from murine models? J Clin Invest 1997;99:557-558.
39. Magistrelli C, Samoilova E, Agarwal RK, et al. Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity. Immunogenetics 1999;49:829-834.
40. Pullmann R Jr, Bonilla E, Phillips PE, et al. Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus. Arthritis Rheum 2008;58:532-540.
41. Perl A, Colombo E, Dai H, et al. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum 1995;38:1660-1671.
42. Banki K, Maceda J, Hurley E, et al. Human T-cell lymphotropic virus (HTLV)- related endogenous sequence, HRES-1, encodes a 28-kDa protein: A possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci U S A 1992;89:1939-1943.
43. Nagy G, Ward J, Mosser DD, et al. Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection. J Biol Chem 2006;281:34574-34591.
44. Fernandez DR, Telarico T, Bonilla E, et al. Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4- regulated lysosomal degradation. J Immunol 2009;182:2063-2073.
45. Hishikawa T, Ogasawara H, Kaneko H, et al. Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases. Viral Immunol 1997;10:137-147.
46. Naito T, Ogasawara H, Kaneko H, et al. Immune abnormalities induced by human endogenous retroviral peptides: With reference to the pathogenesis of systemic lupus erythematosus. J Clin Immunol 2003;23:371-376.
47. Ogasawara H, Hishikawa T, Sekigawa I, et al. Sequence analysis of human endogenous retrovirus clone 4-1 in systemic lupus erythematosus. Autoimmunity 2000;33:15-21.
48. Piotrowski PC, Duriagin S, Jagodzinski PP. Expression of human endogenous retrovirus clone 4-1 may correlate with blood plasma concentration of anti-U1 RNP and anti-Sm nuclear antibodies. Clin Rheumatol 2005;24:620-624.
49. Hohenadl C, Germaier H, Walchner M, et al. Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation. J Invest Dermatol 1999;113:587-594.
50. Li JM, Fan WS, Horsfall AC, et al. The expression of human endogenous retrovirus- 3 in fetal cardiac tissue and antibodies in congenital heart block. Clin Exp Immunol 1996;104:388-393.
51. Herve CA, Lugli EB, Brand A, et al. Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes. Clin Exp Immunol 2002;128:75-82.
52. Sander DM, Szabo S, Gallaher WR, et al. Involvement of human intracis- ternal A-type retroviral particles in autoimmunity. Microsc Res Tech 2005;68: 222-234.
53. Deas JE, Liu LG, Thompson JJ, et al. Reactivity of sera from systemic lupus erythematosus and Sjogren's syndrome patients with peptides derived from human immunodeficiency virus p24 capsid antigen. Clin Diagn Lab Immunol 1998;5:181-185.
54. Blomberg J, Nived O, Pipkorn R, et al. Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Correlation with autoantibodies and clinical manifestations. Arthritis Rheum 1994;37:57-66.
55. Sekigawa I, Okada M, Ogasawara H, et al. Lessons from similarities between SLE and HIV infection. J Infect 2002;44:67-72.
56. Talal N, Flescher E, and Dang H. Are endogenous retroviruses involved in human autoimmune disease? J Autoimmun 1992;5(Suppl A):61-66.
57. Marguerat S, WangWY, Todd JA, and Conrad B. Association of human endogenous retrovirus K-18 polymorphisms with type 1 diabetes. Diabetes 2004;53:852-854.
58. Conrad B, Weidmann E, Trucco G, et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994;371:351-355.
59. Lan MS, Mason A, Coutant R, et al. HERV-K10s and immune-mediated (type 1) diabetes. Cell 1998;95:14-16; discussion 16.
60. Lower R, Tonjes RR, Boller K, et al. Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retro- virus HERV-K. Cell 1998;95:11-14; discussion 16.
61. Murphy VJ, Harrison LC, Rudert WA, et al. Retroviral superantigens and type 1 diabetes mellitus. Cell 1998;95:9-11; discussion 16.
62. Lapatschek M, Durr S, Lower R, et al. Functional analysis of the env open reading frame in human endogenous retrovirus IDDMK(1,2)22 encoding superantigen activity. J Virol 2000;74:6386-6393.
63. Ramos-Lopez E, Ghebru S, Van Autreve J, et al. Neither an intronic CA repeat within the CD48 gene nor the HERV-K18 polymorphisms are associated with type 1 diabetes. Tissue Antigens 2006;68:147-152.
64. Conrad B, Weissmahr RN, Boni J, et al. A human endogenous retroviral super- antigen as candidate autoimmune gene in type I diabetes. Cell 1997;90:303-313.
65. Bieda K, Pani MA, Auwera B Van Der, et al. A retroviral long terminal repeat adjacent to the HLA DQB1 gene (DQ-LTR13) modifies type I diabetes susceptibility on high risk DQ haplotypes. Diabetologia 2002;45:443-447.
66. Blond JL, Beseme F, Duret L, et al. Molecular characterization and placen- tal expression of HERV-W, a new human endogenous retrovirus family. J Virol 1999;73:1175-1185.
67. Perron H, Garson JA, Bedin F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A 1997;94:7583-7588.
68. Perron H, Geny C, Laurent A, et al. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 1989;140:551-561.
69. Perron H, Lalande B, Gratacap B, et al. Isolation of retrovirus from patients with multiple sclerosis. Lancet 1991;337:862-863.
70. Sotgiu S, Serra C, Mameli G, et al. Multiple sclerosis-associated retrovirus and MS prognosis: An observational study. Neurology 2002;59:1071-1073.
71. Sotgiu S, Arru G, Mameli G, et al. Multiple sclerosis-associated retrovirus in early multiple sclerosis: A six-year follow-up of a Sardinian cohort. Mult Scler 2006;12:698-703.
72. Antony JM, Zhu Y, Izad M, et al. Comparative expression of human endogenous retrovirus-W genes in multiple sclerosis. AIDS Res Hum Retroviruses 2007;23:1251-1256.
73. Mameli G, Poddighe L, Astone V, et al. Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis. J Virol Methods 2009;161:98-106.
74. Antony JM, Izad M, Bar-Or A, et al. Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases. AIDS Res Hum Retroviruses 2006;22:1253-1259.
75. Firouzi R, Rolland A, Michel M, et al. Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model. J Neurovirol 2003;9:79-93.
76. Antony JM, Marle G van, Opii W, et al. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 2004;7:1088-1095.
77. Perron H, Jouvin-Marche E, Michel M, et al. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology 2001;287:321-332.
78. Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 2005;15:179-211.
79. Johnston JB, Silva C, Holden J, et al. Monocyte activation and differentiation augment human endogenous retrovirus expression: Implications for inflammatory brain diseases. Ann Neurol 2001;50:434-442.
80. Christensen T, Sorensen P Dissing, Riemann H, et al. Molecular characterization of HERV-H variants associated with multiple sclerosis. Acta Neurol Scand 2000;101:229-238.
81. Brudek T, Christensen T, Aagaard L, et al. B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV- H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology 2009;6:104.
82. Ruprecht K, Gronen F, Sauter M, et al. Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis. J Neurovirol 2008;14:143-151.
83. Moyes DL, Martin A, Sawcer S, et al. The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics 2005;86:337-341.
84. Tai AK, O'Reilly EJ, Alroy KA, et al. Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis. Mult Scler 2008;14:1175-1180.
85. Kwun HJ, Han HJ, Lee WJ, et al. Transactivation of the human endogenous retrovirus K long terminal repeat by herpes simplex virus type 1 immediate early protein 0. Virus Res 2002;86:93-100.
86. Lee WJ, Kwun HJ, Kim HS, and Jang KL. Activation of the human endogenous retrovirus W long terminal repeat by herpes simplex virus type 1 immediate early protein 1. Mol Cells 2003;15:75-80.
87. Sutkowski N, Conrad B, Thorley-Lawson DA, and Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001;15:579-589.
88. Brudek T, Christensen T, Hansen HJ, et al. Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: Implications for multiple sclerosis. AIDS Res Hum Retroviruses 2004;20:415-423.
89. Brudek T, Luhdorf P, Christensen T, et al. Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV- 1, HHV-6 and VZV. J Neuroimmunol 2007;187:147-155.
90. Tai AK, Luka J, Ablashi D, and Huber BT. HHV-6A infection induces expression of HERV-K18-encoded superantigen. J Clin Virol 2009;46:47-48.
91. Garry RF, Fermin CD, Hart DJ, et al. Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 1990;250:1127-1129.
92. Yamano S, Renard JN, Mizuno F, et al. Retrovirus in salivary glands from patients with Sjogren's syndrome. J Clin Pathol 1997;50:223-230.
93. Shattles WG, Brookes SM, Venables PJ, et al. Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjogren's syndrome. Clin Exp Immunol 1992;89:46-51.
94. Eguchi K, Matsuoka N, Ida H, et al. Primary Sjogren's syndrome with antibodies to HTLV-I: Clinical and laboratory features. Ann Rheum Dis 1992;51: 769-776.
95. Terada K, Katamine S, Eguchi K, et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren's syndrome. Lancet 1994;344:1116-1119.
96. Ehlhardt S, Seifert M, Schneider J, et al. Human endogenous retrovirus HERV-K (HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia. J Rheumatol 2006;33:16-23.
97. Sicat J, Sutkowski N, and Huber BT. Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis. J Rheumatol 2005;32:1821-1831.
98. Stransky G, Vernon J, Aicher WK, et al. Virus-like particles in synovial fluids from patients with rheumatoid arthritis. Br J Rheumatol 1993;32:1044-1048.
99. Ziegler B, Gay RE, Huang GQ, et al. Immunohistochemical localization of HTLV- I p19- and p24-related antigens in synovial joints of patients with rheumatoid arthritis. Am J Pathol 1989;135:1-5.
100. Ziegler BL, Thomas CA. Detection of HIV-1 related antigens in rheumatoid synovial tissues. Acta Histochem Cytochem 1991;24:1-9.
101. Griffiths DJ, Cooke SP, Herve C, et al. Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus. Arthritis Rheum 1999;42: 448-454.
102. Piper KE, Hanssen AD, Lewallen DG, et al. Lack of detection of human retrovirus- 5 proviral DNA in synovial tissue and blood specimens from individuals with rheumatoid arthritis or osteoarthritis. Arthritis Rheum 2006;55:123-125.
103. Forsman A, Uzameckis D, Ronnblom L, et al. Single-tube nested quantitative PCR: A rational and sensitive technique for detection of retroviral DNA. Application to RERV-H/HRV-5 and confirmation of its rabbit origin. J Virol Methods 2003;111:1-11.
104. Ejtehadi HD, Freimanis GL, Ali HA, et al. The potential role of human endogenous retrovirus K10 in the pathogenesis of rheumatoid arthritis: A preliminary study. Ann Rheum Dis 2006;65:612-616.
105. Reynier F, Verjat T, Turrel F, et al. Increase in human endogenous retrovirus HERV-K (HML-2) viral load in active rheumatoid arthritis. Scand J Immunol 2009;70:295-299.
106. Talal N, Flescher E, and Dang H. Evidence for possible retroviral involvement in autoimmune diseases. Ann Allergy 1992;69:221-224.
107. Mason AL, Xu L, Guo L, et al. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1998;351:1620-1624.
108. Jaspan JB, Luo H, Ahmed B, et al. Evidence for a retroviral trigger in Graves' disease. Autoimmunity 1995;20:135-142.
109. Xu L, Shen Z, Guo L, et al. Does a beta retrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci U S A 2003;100:8454-8459.
110. McDermid J, Chen M, Li Y, et al. Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Aliment Pharmacol Ther 2007;26:587-595.
111. Selmi C, Ross SR, Ansari AA, et al. Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gas- troenterology 2004;127:493-501.
112. Pani MA, Seidl C, Bieda K, et al. Preliminary evidence that an endogenous retroviral long-terminal repeat (LTR13) at the HLA-DQB1 gene locus confers susceptibility to Addison's disease. Clin Endocrinol (Oxf) 2002;56:773-777.
113. Gambelunghe G, Kockum I, Bini V, et al. Retrovirus-like long-terminal repeat DQ- LTR13 and genetic susceptibility to type 1 diabetes and autoimmune Addison's disease. Diabetes 2005;54:900-905.
114. La Placa M, Vitone F, Bianchi T, et al. Serum antibodies against human intracis- ternal A-type particle (HIAP) endogenous retrovirus in Alopecia areata patients: A hallmark of autoimmune disease? J Invest Dermatol 2004;123:407-409.
115. Moles JP, Hadi JC, and Guilhou JJ. High prevalence of an IgG response against murine leukemia virus (MLV) in patients with psoriasis. Virus Res 2003;94:97-101.
116. Moles JP, Tesniere A, and Guilhou JJ. Reverse transcriptase activity in human normal and psoriatic skin samples. Br J Dermatol 2007;157:482-486.
117. Bessis D, Moles JP, Basset-Seguin N, et al. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin. Br J Dermatol 2004;151:737-745.
118. Moles JP, Tesniere A, and Guilhou JJ. A new endogenous retroviral sequence is expressed in skin of patients with psoriasis. Br J Dermatol 2005;153:83-89.
119. Foerster J, Nolte I, Junge J, et al. Haplotype sharing analysis identifies a retro- viral dUTPase as candidate susceptibility gene for psoriasis. J Invest Dermatol 2005;124:99-102.